Biote Corp Stock Forward View
| BTMD Stock | USD 2.10 -0.10 -4.55% |
This Naive Prediction projection for Biote Corp is fitted to the equity's recent daily closes. Low error metrics relative to the price level indicate the model fits recent trading behavior well. The Naive Prediction model projects Biote Corp at 1.81 for the next trading day, below the most recent closing price. This forecast is one analytical input among many and should be assessed in the context of broader analysis.
Naive Prediction Price Forecast For the 8th of May
Over a 90-day horizon, the Naive Prediction model forecasts Biote Corp at 1.81 for the next trading day, with a mean absolute deviation of 0.09 , mean absolute percentage error of 0.05 , and sum of absolute errors of 5.60 .This indicates moderate forecast accuracy — the model captures the general trend but not all short-term variation in Biote Corp's price. This output is intended for short-term analytical reference.
Stock Forecast Pattern
| Backtest Biote Corp | Biote Corp Price Prediction | Research Analysis |
Forecasted Value
The projected range for Biote Corp reflects the model's ability to define credible downside and upside scenarios for the next trading day. Downside is estimated near 0.02 and upside near 6.33. The wide range indicates elevated uncertainty in short-term projections.
Model Predictive Factors
The table below summarizes the Naive Prediction model's error metrics for Biote Corp stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.| AIC | Akaike Information Criteria | 113.6306 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0918 |
| MAPE | Mean absolute percentage error | 0.0509 |
| SAE | Sum of the absolute errors | 5.6003 |
Other Forecasting Options for Biote Corp
The autocorrelation structure of Biote Corp's daily returns reveals whether Biote Corp exhibits momentum, mean-reversion, or random-walk behavior. Separating these elements distinguishes persistent directional moves from temporary noise in Biote Corp Stock price data.Biote Corp Related Equities
Biote Corp's market space within the Health Care space is illustrated by the firms listed below. Checking cash flow across this peer set helps gauge Biote Corp's relative financial strength.
| Risk & Return | Correlation |
Biote Corp Market Strength Events
Rate of Change and Momentum readings for Biote Corp measure the velocity of recent price moves rather than direction alone. These indicators add context to how recent sessions in Biote Corp have behaved.
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 2.1 | |||
| Day Typical Price | 2.1 | |||
| Price Action Indicator | -0.05 | |||
| Period Momentum Indicator | -0.10 | |||
| Relative Strength Index | 53.18 |
Biote Corp Risk Indicators
Standard deviation and variance for Biote Corp measure total price dispersion, while semi-deviation isolates only the downside moves. Higher variance relative to sector peers signals that Biote Corp's price path has been less predictable over the measured period.
| Mean Deviation | 3.32 | |||
| Semi Deviation | 4.16 | |||
| Standard Deviation | 4.53 | |||
| Variance | 20.5 | |||
| Downside Variance | 20.51 | |||
| Semi Variance | 17.32 | |||
| Expected Short fall | -3.90 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Biote Corp Short Properties
Short-interest data for Biote Corp reveals whether bearish conviction in the market is gaining traction. Comparing short sentiment with trend behavior, volume, and the broader market narrative provides a more grounded view.
| Common Stock Shares Outstanding | 36.67 million | |
| Cash And Short Term Investments | 24.12 million |